Home

Leap Therapeutics, Inc. (LPTX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Leap Therapeutics, Inc. (LPTX)

Go deeper and ask any question about LPTX

Company Performance

Current Price

as of Sep 13, 2024

$2.74

P/E Ratio

N/A

Market Cap

$104.84M

Description

Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerLPTX
  • Price$2.74-2.49%

Trading Information

  • Market Cap$104.84M
  • Float77.70%
  • Average Daily Volume (1m)86,184
  • Average Daily Volume (3m)110,806
  • EPS-$2.00

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$20.13M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$21.25M
  • EV-$1.32M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
Documents